On Feb 21, 2022 Jagsonpal Pharmaceuticals closed a Post-IPO Equity round and raised ₹2,690,000,000 from Convergent Finance, featuring lead investors Convergent Finance.
About the company: Jagsonpal Pharmaceuticals is located at India, Asia.
“”
Company website: http://www.jagsonpal.com